Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/116226
Title: | ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model |
Author: | Moles Meler, Ernest Galiano, Silvia Gomes, Ana Quiliano, Miguel Teixeira, Catia Marlene Aldana, Ignacio Gomes, Paula A. C Fernàndez Busquets, Xavier |
Keywords: | Malària Nanomedicina Plasmodium falciparum Malaria Nanomedicine Plasmodium falciparum |
Issue Date: | 15-Aug-2017 |
Publisher: | Elsevier Science |
Abstract: | Most drugs currently entering the clinical pipeline for severe malaria therapeutics are of lipophilic nature, with a relatively poor solubility in plasma and large biodistribution volumes. Low amounts of these compounds do consequently accumulate in circulating Plasmodium-infected red blood cells, exhibiting limited antiparasitic activity. These drawbacks can in principle be satisfactorily dealt with by stably encapsulating drugs in targeted nanocarriers. Here this approach has been adapted for its use in immunocompetent mice infected by the Plasmodium yoelii 17XL lethal strain, selected as a model for human blood infections by Plasmodium falciparum. Using immunoliposomes targeted against a surface protein characteristic of the murine erythroid lineage, the protocol has been applied to two novel antimalarial lipophilic drug candidates, an aminoquinoline and an aminoalcohol. Large encapsulation yields of >90% were obtained using a citrate-buffered pH gradient method and the resulting immunoliposomes reached in vivo erythrocyte targeting and retention efficacies of >80%. In P. yoelii-infected mice, the immunoliposomized aminoquinoline succeeded in decreasing blood parasitemia from severe to uncomplicated malaria parasite densities (i.e. from >/=25% to ca. 5%), whereas the same amount of drug encapsulated in non-targeted liposomes had no significant effect on parasite growth. Pharmacokinetic analysis indicated that this good performance was obtained with a rapid clearance of immunoliposomes from the circulation (blood half-life of ca. 2 h), suggesting a potential for improvement of the proposed model. |
Note: | Reproducció del document publicat a: http://dx.doi.org/10.1016/j.biomaterials.2017.08.020 |
It is part of: | Biomaterials, 2017, vol. 145, num. , p. 178-191 |
URI: | http://hdl.handle.net/2445/116226 |
Related resource: | http://dx.doi.org/10.1016/j.biomaterials.2017.08.020 |
ISSN: | 0142-9612 |
Appears in Collections: | Articles publicats en revistes (ISGlobal) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
moles2017_2681.pdf | 4.7 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License